Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Boers

Showing results (221-230 of 308) with videos related to

Pageof 31
Sort By:
Seminars in Arthritis and Rheumatism|September 3, 2023
Effects of secukinumab on synovitis and enthesitis in patients with psoriatic arthritis: 52-week clinical and ultrasound results from the randomised, double-blind ULTIMATE trial with open label extensionMaria Antonietta D'Agostino, Philippe Carron, Corine Gaillez, et al.
The Journal of Rheumatology|March 9, 2007
Testing of the preliminary OMERACT validation criteria for a biomarker to be regarded as reflecting structural damage endpoints in rheumatoid arthritis clinical trials: the example of C-reactive proteinStephanie O Keeling, Robert Landewe, Desiree van der Heijde, et al.
The Journal of Rheumatology|February 3, 2020
Feasibility and Face Validity of Outcome Measures for Use in Future Studies of Polymyalgia Rheumatica: An OMERACT StudyMax Yates, Claire E Owen, Sara Muller, et al.
The Journal of Rheumatology|February 17, 2019
Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT MethodologyLara J Maxwell, Dorcas E Beaton, Beverley J Shea, et al.
Rheumatology (Oxford, England)|July 31, 2015
Validity and measurement precision of the PROMIS physical function item bank and a content validity-driven 20-item short form in rheumatoid arthritis compared with traditional measuresMartijn A H Oude Voshaar, Peter M Ten Klooster, Cees A W Glas, et al.
The Journal of Rheumatology|December 17, 2013
OMERACT endorsement of measures of outcome for studies of acute goutJasvinder A Singh, William J Taylor, Nicola Dalbeth, et al.
Plos One|March 19, 2014
Calibration of the PROMIS physical function item bank in Dutch patients with rheumatoid arthritisMartijn A H Oude Voshaar, Peter M ten Klooster, Cees A W Glas, et al.
The Journal of Rheumatology|May 17, 2019
Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal StudyRabia Agca, Luuk H G A Hopman, Koen J C Laan, et al.
Trials|January 27, 2018
Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trialLinda Hartman, Linda A Rasch, Thomas Klausch, et al.
The Journal of Rheumatology|February 3, 2019
Instrument Selection Using the OMERACT Filter 2.1: The OMERACT MethodologyDorcas E Beaton, Lara J Maxwell, Beverley J Shea, et al.
Pageof 31

Showing results (221-230 of 308) with videos related to

Sort By:
Pageof 31
Seminars in Arthritis and Rheumatism|September 3, 2023
Effects of secukinumab on synovitis and enthesitis in patients with psoriatic arthritis: 52-week clinical and ultrasound results from the randomised, double-blind ULTIMATE trial with open label extensionMaria Antonietta D'Agostino, Philippe Carron, Corine Gaillez, et al.
The Journal of Rheumatology|March 9, 2007
Testing of the preliminary OMERACT validation criteria for a biomarker to be regarded as reflecting structural damage endpoints in rheumatoid arthritis clinical trials: the example of C-reactive proteinStephanie O Keeling, Robert Landewe, Desiree van der Heijde, et al.
The Journal of Rheumatology|February 3, 2020
Feasibility and Face Validity of Outcome Measures for Use in Future Studies of Polymyalgia Rheumatica: An OMERACT StudyMax Yates, Claire E Owen, Sara Muller, et al.
The Journal of Rheumatology|February 17, 2019
Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT MethodologyLara J Maxwell, Dorcas E Beaton, Beverley J Shea, et al.
Rheumatology (Oxford, England)|July 31, 2015
Validity and measurement precision of the PROMIS physical function item bank and a content validity-driven 20-item short form in rheumatoid arthritis compared with traditional measuresMartijn A H Oude Voshaar, Peter M Ten Klooster, Cees A W Glas, et al.
The Journal of Rheumatology|December 17, 2013
OMERACT endorsement of measures of outcome for studies of acute goutJasvinder A Singh, William J Taylor, Nicola Dalbeth, et al.
Plos One|March 19, 2014
Calibration of the PROMIS physical function item bank in Dutch patients with rheumatoid arthritisMartijn A H Oude Voshaar, Peter M ten Klooster, Cees A W Glas, et al.
The Journal of Rheumatology|May 17, 2019
Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal StudyRabia Agca, Luuk H G A Hopman, Koen J C Laan, et al.
Trials|January 27, 2018
Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trialLinda Hartman, Linda A Rasch, Thomas Klausch, et al.
The Journal of Rheumatology|February 3, 2019
Instrument Selection Using the OMERACT Filter 2.1: The OMERACT MethodologyDorcas E Beaton, Lara J Maxwell, Beverley J Shea, et al.
Pageof 31